FONDAPARINUX vs FOSAPREPITANT DIMEGLUMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FONDAPARINUX vs FOSAPREPITANT DIMEGLUMINE: Safety Overview
| Metric | FONDAPARINUX | FOSAPREPITANT DIMEGLUMINE |
|---|---|---|
| Total FAERS Reports | 2,230 | 888 |
| Deaths Reported | 308 | 118 |
| Death Rate | 13.8% | 13.3% |
| Hospitalizations | 1,141 | 364 |
| Average Patient Age | 63.2 yrs | 57.0 yrs |
| % Female Patients | 56.5% | 50.1% |
| FDA Approval Date | Aug 19, 2024 | Aug 20, 2020 |
| Manufacturer | Dr. Reddy's Laboratories Limited | Dr. Reddy's Laboratories Inc., |
| Route | SUBCUTANEOUS | INTRAVENOUS |
| Marketing Status | Prescription | Discontinued |